Compassionate use of remdesivir in children with COVID-19

被引：0
作者：
Ana Méndez-Echevarría
Antonio Pérez-Martínez
Luis Gonzalez del Valle
María Fátima Ara
Susana Melendo
Marta Ruiz de Valbuena
Jose Luis Vazquez-Martinez
Antonio Morales-Martínez
Agustín Remesal
Kinga Amália Sándor-Bajusz
Fernando Cabañas
Cristina Calvo
机构：
[1] La Paz University Hospital,Paediatric Infectious Diseases Department, Translational Research Network in Paediatric Infectious Diseases (RITIP)
[2] La Paz University Hospital,Paediatric Hemato
[3] La Paz Institute for Health Research (IdiPAZ),Oncology Department, Translational Research in Pediatric Oncology, Hematopoietic Transplantation and Cell Therapy
[4] La Paz University Hospital,Pharmacy Department
[5] Quironsalud Madrid University Hospital,Department of Paediatrics and Neonatology
[6] Hospital Universitari Vall d’Hebron (HUVH). Vall d’Hebron Research Institute (VHIR),Paediatric Infectious Diseases and Immunodeficiencies Unit
[7] La Paz University Hospital,Pediatric Pulmunology Unit
[8] Ramon y Cajal Universitary Hospital,Paediatric Intensive Care Unit
[9] Universitary Regional Málaga Hospital,Paediatric Intensive Care Unit
[10] La Paz University Hospital,Paediatric Rheumatology Unit
[11] University of Pécs Medical School,Department of Paediatrics
[12] Quironsalud Madrid University Hospital and Biomedical Research Foundation,Department of Neonatology
[13] La Paz University Hospital Madrid,undefined
来源：
European Journal of Pediatrics | 2021年 / 180卷
关键词：
SARS-CoV-2; COVID-19; Remdesivir; Children; Infant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Children represent a minority of total COVID-19 cases, but studies have reported severe disease and death in pediatric patients. Remdesivir (RDV) has recently demonstrated promising results in adults with COVID-19, but few data have been reported to date in children.
引用
收藏
页码：1317 / 1322
页数：5
相关论文
共 197 条
  • [1] Wang Y(2020)Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial Lancet. 395 1569-1578
  • [2] Zhang D(2020)Remdesivir for the Treatment of Covid-19 - Final Report N Engl J Med 383 1813-1826
  • [3] Du G(2020)Simulated assessment of pharmacokinetically guided dosing for investigational treatments of pediatric patients with coronavirus disease 2019 JAMA Pediatr 174 e202422-661
  • [4] Du R(2020)COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study Lancet Child Adolesc Health 4 653-1088
  • [5] Zhao J(2020)Hospitalization rates and characteristics of children aged <18 years hospitalized with laboratory-confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020 Morb Mortal Wkly Rep 69 1081-7
  • [6] Jin Y(2020)Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report Mod Rheumatol Case Rep 20 1-407
  • [7] Beigel JH(2020)Screening and severity of coronavirus disease 2019 (COVID-19) in children in Madrid JAMA Pediatr 8 e201346-undefined
  • [8] Tomashek KM(2020)COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal J Heart Lung Transplant 39 405-undefined
  • [9] Dodd LE(2020)Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: a descriptive study J Clin Virol 127 104346-undefined
  • [10] Mehta AK(undefined)undefined undefined undefined undefined-undefined
12345678910